Novartis has terminated a mid-stage trial of an oral treatment candidate for idiopathic pulmonary fibrosis, the company confirmed to Endpoints News.
The Swiss pharma giant …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A review in Nature Reviews Materials explores the potential of edible materials in creating robotic foods and edible robots, highlighting their therapeutic and environmental benefits,
In February, we reported on how the Medical Board of California filed an accusation against Simone Gold, MD, JD, putting her medical license at stake.
The Centers for Disease Control and Prevention (CDC) has awarded $17.5 million to a coalition led by researchers at UC San Diego to develop innovative